BRIGHENTI, ELISA

BRIGHENTI, ELISA  

DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.037 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease C. Calabrese; L. Montanaro; G. Liguori; E. Brighenti; M. Vici; P. Gionchetti; F. Rizzello; M. Cam...pieri; M. Derenzini; D. Trerè 2011-01-01 WORLD JOURNAL OF GASTROENTEROLOGY - 1.01 Articolo in rivista -
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma Derenzini, Enrico; Agostinelli, Claudio; Imbrogno, Enrica; Iacobucci, Ilaria; Casadei, Beatrice; ...Brighenti, Elisa; Righi, Simona; Fuligni, Fabio; Ghelli Luserna Di Rorà, Andrea; Ferrari, Anna; Martinelli, Giovanni; Pileri, Stefano; Zinzani, Pier Luigi 2015-01-01 ONCOTARGET - 1.01 Articolo in rivista -
Direct relationship between the level of p53 stabilization induced by rRNA synthesis-inhibiting drugs and the cell ribosome biogenesis rate Scala, F.; Brighenti, E.; Govoni, M.; Imbrogno, E.; Fornari, F.; Treré, D.; Montanaro, L.; Derenz...ini, M 2016-01-01 ONCOGENE - 1.01 Articolo in rivista -
High prevalence of retinoblastoma protein loss in triple-negative breast cancers and its association with a good prognosis in patients treated with adjuvant chemotherapy. Treré D; Brighenti E; Donati G; Ceccarelli C; Santini D; Taffurelli M; Montanaro L; Derenzini M. 2009-01-01 ANNALS OF ONCOLOGY - 1.01 Articolo in rivista -
Inhibition of DNA repair by the small molecule Chk1/Chk2 inhibitor PF-0477736 (Pfizer) in B-acute lymphoblastic leukemia (ALL) Iacobucci I; Cattina F; Pomella S; Brighenti E; Papayannidis C; Derenzini E; Lonetti A; Ferrari A...; Verga Falzacappa MV; Guadagnuolo V; Aluigi M; Ottaviani E; Abbenante MC; Soverini S; Russo D; Pelicci PG; Baccarani M; Martinelli G 2012-01-01 CANCER RESEARCH - 4.02 Riassunto (Abstract) -
The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis Brighenti, Elisa; Carnicelli, Domenica; Brigotti, Maurizio; Fiume, Luigi 2017-01-01 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS - 1.01 Articolo in rivista -
Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer. Brighenti E;Calabrese C;Liguori G;Giannone FA;Trerè D;Montanaro L;Derenzini M 2014-01-01 ONCOGENE - 1.01 Articolo in rivista -
Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade. Tavolari S.; Bonafè M.; Marini M.; Ferreri C.; Bartolini G.; Brighenti E.; Manara S.; Tomasi V.; ...Laufer S.; Guarnieri T. 2008-01-01 CARCINOGENESIS - 1.01 Articolo in rivista -
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) Ilaria Iacobucci, Federica Cattina, Silvia Pomella, Annalisa Lonetti, Enrico Derenzini, Elisa Bri...ghenti, Anna Ferrari, Cristina Papayannidis, Maria Vittoria Verga Falzacappa, Viviana Guadagnuolo, Michela Aluigi, Emanuela Ottaviani, Serena Formica, Maria Chiara Abbenante, Simona Soverini, Domenico Russo, Fabrizio Pane, Pier Guiseppe Pellicci, Michele Baccarani, Giovanni Martinelli 2011-01-01 BLOOD - 1.06 Abstract in rivista -
Selective inhibition of rRNA transcription downregulates E2F-1: a new p53-independent mechanism linking cell growth to cell proliferation. Donati G; Brighenti E; Vici M; Mazzini G; Treré D; Montanaro L; Derenzini M. 2011-01-01 JOURNAL OF CELL SCIENCE - 1.01 Articolo in rivista -
Targeted cancer therapy with ribosome biogenesis inhibitors: A real possibility? Brighenti, Elisa; Treré, Davide; Derenzini, Massimo 2015-01-01 ONCOTARGET - 1.01 Articolo in rivista 5775-78933-2-PB.pdf
The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Donati G; Bertoni S; Brighenti E; Vici M; Treré D; Volarevic S; Montanaro L; Derenzini M. 2011-01-01 ONCOGENE - 1.01 Articolo in rivista -
The p53-mediated sensitivity of cancer cells to chemotherapeutic agents is conditioned by the status of the retinoblastoma protein. Derenzini M; Brighenti E; Donati G; Vici M; Ceccarelli C; Santini D; Taffurelli M; Montanaro L; T...reré D. 2009-01-01 JOURNAL OF PATHOLOGY - 1.01 Articolo in rivista -
Therapeutic dosages of aspirin counteract the IL-6 induced pro-tumorigenic effects by slowing down the ribosome biogenesis rate Brighenti, Elisa; Giannone, Ferdinando Antonino; Fornari, Francesca; Onofrillo, Carmine; Govoni, ...Marzia; Montanaro, Lorenzo; Treré, Davide; Derenzini, Massimo 2016-01-01 ONCOTARGET - 1.01 Articolo in rivista Oncotarget2016Brighenti.pdf